Page last updated: 2024-08-17

adenosine diphosphate and thrombin receptor peptide (42-55)

adenosine diphosphate has been researched along with thrombin receptor peptide (42-55) in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's8 (57.14)18.2507
2000's4 (28.57)29.6817
2010's1 (7.14)24.3611
2020's1 (7.14)2.80

Authors

AuthorsStudies
Cook, NS; Hagenbach, A; Metternich, R; Powling, M; Singh, J; Tapparelli, C; Zerwes, HG1
Dol, F; Herbert, JM; Savi, P1
Boudignon-Proudhon, C; Criss, AB; Dieter, MG; Parise, LV; Wencel-Drake, JD1
Barnard, MR; Benoit, SE; Furman, MI; Michelson, AD; Nurden, AT; Nurden, P1
Kawasaki, T; Kawashima, H; Maruyama, K; Sakai, Y; Shimizu, M; Takenaka, T; Taniuchi, Y1
Carroll, RC; Kouns, WC; Lanza, F; Steiner, B; Wang, XF1
Théroux, P; Xiao, Z1
Barnard, MR; Becker, RC; Benoit, SE; Borbone, ML; Furman, MI; Hechtman, HB; Michelson, AD; Valeri, CR1
Modi, NB; Novotny, W; Reimann, JD1
Gebauer, MU; Haeberli, A; Julmy, F; Meyer, BJ; Moshfegh, K; Redondo, M; Wuillemin, WA1
Elisaf, M; Goudevenos, JA; Mitsios, JV; Papathanasiou, AI; Rodis, FI; Tselepis, AD1
Elisaf, M; Goudevenos, JA; Mitsios, JV; Papathanasiou, AI; Tselepis, AD1
Fiore, M; Pillois, X; Pouget, T1
Do Sacramento, V; Eckly, A; Freund, M; Gachet, C; Hechler, B; Lanza, F; Mallo, L; Mangin, P; Strassel, C1

Trials

4 trial(s) available for adenosine diphosphate and thrombin receptor peptide (42-55)

ArticleYear
Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor.
    Circulation, 1998, Jan-27, Volume: 97, Issue:3

    Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Angina, Unstable; Anticoagulants; Antithrombins; Arginine; Dose-Response Relationship, Drug; Enoxaparin; Female; Heparin; Humans; Male; Middle Aged; P-Selectin; Partial Thromboplastin Time; Peptide Fragments; Pipecolic Acids; Platelet Activation; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Sulfonamides

1998
Pharmacokinetics and pharmacodynamics of sibrafiban, an orally administered GP IIb/IIIa antagonist, following coadministration of aspirin and heparin.
    Journal of clinical pharmacology, 2000, Volume: 40, Issue:5

    Topics: Adenosine Diphosphate; Administration, Oral; Adult; Anticoagulants; Area Under Curve; Aspirin; Bleeding Time; Cross-Over Studies; Drug Interactions; Female; Heparin; Humans; Male; Middle Aged; Oximes; Partial Thromboplastin Time; Peptide Fragments; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prodrugs; Prothrombin Time; Receptors, Thrombin

2000
Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy.
    Journal of the American College of Cardiology, 2000, Volume: 36, Issue:3

    Topics: Adenosine Diphosphate; Adult; Aged; Antigens, CD; Aspirin; Blood; Clopidogrel; Collagen; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dual Specificity Phosphatase 2; Humans; Middle Aged; Myocardial Infarction; P-Selectin; Peptide Fragments; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Prospective Studies; Protein Phosphatase 2; Protein Tyrosine Phosphatases; Tetraspanin 30; Ticlopidine

2000
Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes.
    Circulation, 2004, Mar-23, Volume: 109, Issue:11

    Topics: Acute Disease; Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Atorvastatin; CD40 Ligand; Clopidogrel; Combined Modality Therapy; Coronary Disease; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Administration Schedule; Drug Interactions; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inactivation, Metabolic; Male; Middle Aged; P-Selectin; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Pravastatin; Pyrroles; Stents; Ticlopidine; Treatment Outcome

2004

Other Studies

10 other study(ies) available for adenosine diphosphate and thrombin receptor peptide (42-55)

ArticleYear
Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists.
    Thrombosis and haemostasis, 1993, Sep-01, Volume: 70, Issue:3

    Topics: Adenosine Diphosphate; Animals; Cricetinae; Fibrinogen; Flow Cytometry; Guinea Pigs; Humans; Macaca mulatta; Peptide Fragments; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Protein Binding; Rats; Species Specificity

1993
ADP-dependence of platelet activation induced by a thrombin receptor agonist.
    Nouvelle revue francaise d'hematologie, 1993, Volume: 35, Issue:2

    Topics: Adenosine Diphosphate; Adenylyl Cyclases; Amino Acid Sequence; Blood Platelets; Humans; In Vitro Techniques; Molecular Sequence Data; Peptide Fragments; Platelet Aggregation; Receptors, Cell Surface; Receptors, Thrombin

1993
Internalization of bound fibrinogen modulates platelet aggregation.
    Blood, 1996, Jan-15, Volume: 87, Issue:2

    Topics: Adenosine Diphosphate; Amino Acid Sequence; Cell Compartmentation; Endocytosis; Fibrinogen; Flow Cytometry; Humans; Microscopy, Fluorescence; Molecular Sequence Data; Peptide Fragments; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Zinc

1996
The platelet surface expression of glycoprotein V is regulated by two independent mechanisms: proteolysis and a reversible cytoskeletal-mediated redistribution to the surface-connected canalicular system.
    Blood, 1996, Feb-15, Volume: 87, Issue:4

    Topics: Actins; Adenosine Diphosphate; Adult; Amino Acid Sequence; Blood Platelets; Calcium; Cathepsin G; Cathepsins; Cell Compartmentation; Cell Degranulation; Cytoskeleton; Epinephrine; Humans; Immunohistochemistry; Leukocyte Elastase; Molecular Sequence Data; Pancreatic Elastase; Peptide Fragments; Platelet Glycoprotein GPIb-IX Complex; Serine Endopeptidases; Thrombin

1996
Isolation and amino acid sequence of flavostatin, a novel disintegrin from the venom of Trimeresurus flavoviridis.
    Peptides, 1997, Volume: 18, Issue:1

    Topics: Adenosine Diphosphate; Amino Acid Sequence; Animals; Chromatography, High Pressure Liquid; Collagen; Crotalid Venoms; Disintegrins; Electrophoresis, Polyacrylamide Gel; Fibrinogen; Intercellular Signaling Peptides and Proteins; Molecular Sequence Data; Oligopeptides; Peptide Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Thrombin; Sequence Analysis; Sequence Homology, Amino Acid

1997
Blocking platelet aggregation inhibits thromboxane A2 formation by low dose agonists but does not inhibit phosphorylation and activation of cytosolic phospholipase A2.
    Thrombosis research, 1997, Oct-15, Volume: 88, Issue:2

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetates; Adenosine Diphosphate; Blood Platelets; Cytoplasmic Granules; Cytosol; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Lysophospholipids; Peptide Fragments; Phosphorylase a; Phosphorylation; Plasma; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Serotonin; Thrombasthenia; Thromboxane A2; Tyrosine; Vasoconstrictor Agents

1997
Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease.
    Journal of the American College of Cardiology, 1998, Volume: 31, Issue:2

    Topics: Adenosine Diphosphate; Adult; Angina Pectoris; Cell Adhesion; Cell Adhesion Molecules; Cell Count; Cell Degranulation; Cell Movement; Coronary Artery Disease; Coronary Disease; Coronary Vessels; Epinephrine; Female; Flow Cytometry; Humans; Leukocytes; Male; Middle Aged; Monocytes; P-Selectin; Peptide Fragments; Platelet Activation; Platelet Aggregation; Receptors, Thrombin; Thrombosis

1998
The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromes.
    Platelets, 2005, Volume: 16, Issue:5

    Topics: Acute Disease; Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Atorvastatin; Blood Platelets; CD40 Ligand; Cholesterol; Cholesterol, LDL; Clopidogrel; Coronary Disease; Drug Administration Schedule; Drug Interactions; Female; Flow Cytometry; Heptanoic Acids; Humans; Male; Middle Aged; P-Selectin; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrroles; Ticlopidine; Triglycerides

2005
Adenylate cyclase inhibition is required for normal redistribution of platelet surface GPIb in response to PAR1 activation.
    Thrombosis research, 2019, Volume: 173

    Topics: Adenosine Diphosphate; Adenylyl Cyclases; Apyrase; Blood Platelets; Humans; Peptide Fragments; Platelet Glycoprotein GPIb-IX Complex; Receptor, PAR-1; Receptors, Purinergic P2Y12; Thrombin

2019
Functional properties of human platelets derived in vitro from CD34
    Scientific reports, 2020, 01-22, Volume: 10, Issue:1

    Topics: Adenosine Diphosphate; Animals; Antigens, CD34; Blood Platelets; Cells, Cultured; Female; Glycoproteins; Hemostasis; In Vitro Techniques; Mice, Transgenic; Peptide Fragments; Platelet Aggregation; Platelet Transfusion; Stem Cells

2020